表紙
市場調査レポート

世界のヒト成長ホルモン (HGH) 市場

Global Human Growth Hormone Market Report: 2015 Edition

発行 Koncept Analytics 商品コード 336016
出版日 ページ情報 英文 53 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
世界のヒト成長ホルモン (HGH) 市場 Global Human Growth Hormone Market Report: 2015 Edition
出版日: 2015年07月24日 ページ情報: 英文 53 Pages
概要

当レポートでは、世界のヒト成長ホルモン (HGH) 市場について調査分析し、概要、市場分析、市場力学、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 ヒト成長ホルモン (HGH)

  • 成長ホルモン (GH) の生理作用
  • GH分泌制御
  • GH欠乏症 (GHD)
  • GH/HGH療法とその他の応用
  • 組み換えヒト成長ホルモン (rhGH)

第2章 HGH市場の分析

  • 世界市場
  • 地域市場
  • VRS-317 市場機会
  • TransCon-HGH 世界市場の機会

第3章 市場力学

  • 主要動向
  • 業界の発展
  • 成長促進要因
  • 課題

第4章 競合情勢

第5章 企業プロファイル

  • 事業概要、財務概要、事業戦略
    • Roche Holdings AG
    • Novo Nordisk
    • Pfizer, Inc.
    • Eli Lilly and Company

第6章 市場見通し

  • 市場予測
  • 予測手法

図表

目次

Pituitary - the master gland of human body is responsible for controlling crucial hormonal secretion, which, in turn, regulates other key aspects of the body such as temperature, growth, thyroid functioning, urination, and production of other hormones. It is a pea sized gland situated at the base of brain and is a major component of human body as it expedites the response towards the surrounding environment and settings.

Any deformity or damage to the pituitary gland can adversely impact the production and activity level of the above mentioned hormones, thereby affecting the body work process and stunting the outcomes especially in the case of growth hormone. Marred pituitary function leads to either over or under secretion of the somatropin that is the growth hormone. Its over secretion causes disfiguration in the body parts like hands, face, feet, etc. whereas, its deficiency impedes the growth of body parts/whole body, thus leading to disease states like dwarfism or gigantism.

It is observed that the growth hormone related problems usually affect children and teenagers, but it is seen to grip adults as well though to a lesser extent. The major factors which vitiate the pituitary operations thus impairing the GH role include kidney malfunction, tumors/cancer especially associated with brain. There are some other unknown causes as well which are termed as idiopathic. Earlier, to deal with these predicaments, growth hormone used to be extracted from the human cadavers but, as time passed and evolution of technology/tools/techniques/R&D took place, the extraction of GH also got altered and many novel innovations and discoveries were made in the respective field.

Nowadays, many leading companies are heavily involved in the R&D process for devising longer acting and sustained release versions of the somatropin which are produced using the recombinant technology. The competition prevalent in the respective industry is heating up day by day. The human growth hormone market is monopolized by a few players viz. Pfizer, NovoNordisk, Eli Lilly, Sandoz and Roche.

The global HGH report discusses the key ongoing trends like global agreement for Long-Acting Human Growth Hormone (HGH-CTP), increasing use of biosimilar version of drugs and continuous growth of recombinant growth hormones market. On the industry development front, the current inclination is towards developing better treatments for Alzheimer's disease and advancements in needle free injections technology. Furthermore, the major factors driving the HGH market include rising cancer and CKD/ESRD cases and increasing healthcare expenditure on worldwide basis. In addition, a few factors posing challenges in front of the HGH industry are the problems in diagnosis of growth hormone deficiency, risks associated with use of recombinant growth hormone therapies and off-label HGH use which, to an extent, are hindering the growth and development of the same.

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

SAMPLE

Table of Contents

1. Human Growth Hormone

  • 1.1. Physiological Effects of Growth Hormone
  • 1.2. GH Secretion Control
  • 1.3. GH Deficiency (GHD)
  • 1.4. Therapeutic and Other Uses of GH/HGH
  • 1.5. Recombinant Human Growth Hormone (rHGH)

2. Human Growth Hormone (HGH) Market Analysis

  • 2.1. Global Market
    • Market Value
    • Market Volume
    • Market Share
    • Pediatric GHD Market
  • 2.2. Regional Markets
    • The US
    • Europe
    • Japan
  • 2.3. VRS-317 Market Opportunity
  • 2.4. TransCon-HGH Global Market Opportunity

3. Market Dynamics

  • 3.1. Key Trends
    • 3.1.1. Global Agreement for Long-Acting HGH-CTP
    • 3.1.2. Increasing Use of Biosimilar Version of Drugs
    • 3.1.3. Continuous Growth in rGH Market
  • 3.2. Industry Developments
    • 3.2.1. Developing Better Treatments for Alzheimer's disease
    • 3.2.2. Advancement in Needle Free Injection Technology
  • 3.3. Growth Drivers
    • 3.3.1. Increasing Cases of Chronic Kidney Disease (CKD)
    • 3.3.2. Increasing Prevalence of Cancer
    • 3.3.3. Rising Healthcare Expenditure
    • 3.3.4. Increasing Global GDP
  • 3.4. Challenges
    • 3.4.1. Problems in Diagnosis of GHD
    • 3.4.2. Risks Associated With Recombinant Human GH Therapy
    • 3.4.3. Off-Label Uses of rHGH Therapy not Well Defined

4. Competitive Landscape

5. Company Profiles

  • 5.1. Roche Holdings AG
    • 5.1.1. Business Overview
    • 5.1.2. Financial Overview
    • 5.1.3. Business Strategies
  • 5.2. Novo Nordisk
    • 5.2.1. Business Overview
    • 5.2.2. Financial Overview
    • 5.1.3. Business Strategies
  • 5.3. Pfizer, Inc.
    • 5.3.1. Business Overview
    • 5.3.2. Financial Overview
    • 5.3.3. Business Strategies
  • 5.4. Eli Lilly and Company
    • 5.4.1. Business Overview
    • 5.4.2. Financial Overview
    • 5.4.3. Business Strategies

6. Market Outlook

  • 6.1. Market Forecast
  • 6.2. Forecast Methodology
    • 6.2.1. Dependent and Independent Variables
    • 6.2.2. Correlation Analysis
    • 6.2.3. Regression Analysis

List of Charts

  • GH's Physiological Effect
  • GH Secretion Control
  • Global Human Growth Hormone Market Value (2010-2015)
  • Global Human Growth Hormone Market Volume (2010-2015)
  • Global HGH Market Share (2014)
  • Global HGH Sales by Growth Disorder Indication (2015E)
  • Worldwide Pediatric GHD Market Opportunity (2014-2020E)
  • The US Pediatric GHD Market (2014-2020E)
  • European Pediatric GHD Market (2014-2020E)
  • Japan's Pediatric GHD Market (2014-2020E)
  • Global Pediatric GHD VRS-317 Market Opportunity (2018E-2024E)
  • Global TransCon HGH Market Opportunity (2019E-2024E)
  • Market Share of Omnitrope and Genotropin (Jan07-Oct12)
  • Quarterly Sales of rGH Products in USD (Jan10- Oct14)
  • People with Alzheimer's disease in the US (2010-2050E)
  • Worldwide Patients with End Stage Renal Disease (2009-2014E)
  • Number of Cancer Cases Worldwide (2008-2014E)
  • Global Healthcare Spending Per Capita (2009-2014E)
  • Global Gross Domestic Product Growth (2009-2014E)
  • Net Income Comparison of Leading GH Producing Companies (2014)
  • R&D Budget of Top Growth Hormones Companies (2014)
  • Roche's Revenues by Business Segments (2014)
  • Roche's Sales and Net Income (2010-2014)
  • Novo Nordisk Revenue Share by Business Segments (2014)
  • Novo Nordisk's Sales and Net Income (2010-2014)
  • Pfizer's Revenue Share by Business Segments (2014)
  • Pfizer's Sales & Net Income (2010-2014)
  • Eli Lilly's Revenues by Segment (2014)
  • Eli Lilly's Sales and Net Income (2010-2014)
  • Global HGH Market Forecast (2012-2018E)

List of Tables

  • VRS-317 US Market Opportunity (2014-2020E)
  • VRS-317 Europe Market Opportunity (2014-2020E)
  • VRS-317 Japan's Market Opportunity (2014-2020E)
  • TransCon HGH US Market Opportunity (2014E-2020E)
  • TransCon HGH Europe Market Opportunity (2014E-2020E)
  • Needle Free Injectors by Technology
  • CKD Prevalence along with Disease Type (US)
  • Once Weekly HGH Competitive Landscape
  • Dependent & Independent Variables (2009-2014)
  • Correlation Matrix
  • Model Summary - Coefficient of Determination
  • Regression Coefficients Output
Back to Top